Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma

32Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: It is still unclear whether micrometastasis of para-aortic lymph nodes (PALNs) in pancreatic ductal adenocarcinoma (PDAC) is tantamount to PALN metastasis detected by hematoxylin and eosin (HE) staining. Methods: A total of 242 patients with PDAC who underwent radical pancreatectomy with PALN dissection were eligible for this study. Micrometastasis in PALNs was evaluated by CAM 5.2 immunohistochemistry. The relationship between PALN status and overall survival (OS) was analyzed. Results: Of the 242 enrolled patients, 25 (10 %) had PALN metastasis detected by HE (PALN HE-positive), and 21 (9 %) had PALN micrometastasis not detected by HE but identified by CAM 5.2 immunohistochemistry. Univariate analysis revealed that patients with PALN micrometastasis (p =.004) and PALN HE positivity (p =.003) had a significantly shorter OS than those without PALN metastasis, whereas no significant difference was observed between the two former groups (p =.874). In multivariate analysis, lack of adjuvant chemotherapy (hazard ratio [HR] 2.43, p

Cite

CITATION STYLE

APA

Komo, T., Murakami, Y., Kondo, N., Uemura, K., Hashimoto, Y., Nakagawa, N., … Sueda, T. (2016). Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology, 23(6), 2019–2027. https://doi.org/10.1245/s10434-016-5120-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free